SEC Form 4 · accession 0001209191-15-067578
Calithera Biosciences, Inc. · CALA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Curtis Hecht
Officer — VP, BUS. & CORP. DEVELOPMENT
Period of report
Aug 20, 2015
Accepted (ET)
Aug 24, 2015 · 5:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 20, 2015 | M | 2,000 | $2.64 | A | 8,625 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $2.64 | Aug 20, 2015 | M | 2,000 | D | — | Apr 21, 2024 | Common Stock | 2,000 | 43,378 | D |
Explanation of responses
- F1Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on May 15, 2015.
- F21/48 of the Option vests in equal monthly installments one month from 04/21/2014. The option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.